Prof. Zhe Zhang 张哲
Chief Physician, Professor
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Systemic treatment for gastric, colorectal, lung, esophageal, liver, and biliary tract cancers. Expertise in chemotherapy, targeted therapy, immunotherapy, and cellular therapies including CAR-T, TCR-T, and TILs.
Dr. Zhang holds a medical doctorate from Fudan University and has 20 years of experience in medical oncology. Research focuses on molecular targeted therapy, immunotherapy, and drug resistance. Dr. Zhang leads two National Natural Science Foundation projects and one Shanghai Natural Science Foundation project, and participated in national major scientific research programs. Over 20 papers have been published in journals such as Clinical Cancer Research.
Professional roles
- Youth Member, Precision Medicine Professional Committee, China Anti-Cancer Association (CACA)
- Member, Clinical Research of Oncology Drugs Professional Committee, Shanghai Anti-Cancer Association
- Member, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Zhang Zhe). Papers usually list the name as Zhe Zhang or Zhang Z.
Selected publications
56 papers on PubMed matched by name and affiliation; 16 as first or senior author since 2016. Most recent first- or senior-author papers:
- Sci Rep, 2026 (senior author): Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancer. PubMed 42259884
- Cancer Biother Radiopharm, 2022 (first author): LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212. PubMed 32598181
- Neoplasia, 2021 (senior author): Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma. PubMed 34303217
- J Biomed Nanotechnol, 2021 (senior author): Cation Lipid-Assisted PEG6-PLGA Polymer Nanoparticles Encapsulated Knocking Down Long ncRNAs Reverse Non-Coding RNA of Xist Through the Support Vector Machine Model to Regulate the Molecular Mechanisms of Gastric Cancer Cell Apoptosis. PubMed 34446134
- Mamm Genome, 2021 (senior author): ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma. PubMed 33934179
- Ann Palliat Med, 2021 (first author): Chemotherapy and targeted therapy near the end of life affects aggressiveness of palliative care. PubMed 33549022
- Cell Biol Toxicol, 2021 (senior author): Short-form RON (sf-RON) enhances glucose metabolism to promote cell proliferation via activating β-catenin/SIX1 signaling pathway in gastric cancer. PubMed 32399910
- Cancer Biother Radiopharm, 2020 (first author): Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer. PubMed 32319822
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion